Ocular Surface Disease clinical trials at University of California Health
1 research study open to eligible people
open to all eligible people
To evaluate glaucoma patients' response to treatment with Xiidra, an FDA-approved drug for ocular surface discomfort, which will be prescribed as standard of care treatment.
Our lead scientists for Ocular Surface Disease research studies include Benjamin B. Bert, MD.